These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 21139151

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Measurement of microbicide acceptability among U.S. adolescent girls.
    Short MB, Perfect MM, Auslander BA, Devellis RF, Rosenthal SL.
    Sex Transm Dis; 2007 Jun; 34(6):362-6. PubMed ID: 17038964
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Magnetic resonance imaging to determine the distribution of a vaginal gel: before, during, and after both simulated and real intercourse.
    Pretorius ES, Timbers K, Malamud D, Barnhart K.
    Contraception; 2002 Dec; 66(6):443-51. PubMed ID: 12499038
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. First real success for anti-HIV gel: a new start for HIV microbicides?
    Ariën KK, Vanham G.
    Future Microbiol; 2010 Nov; 5(11):1621-3. PubMed ID: 21133683
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Safety and acceptability of 6% cellulose sulfate vaginal gel applied four times per day for 14 days.
    Doh AS, Ngoh N, Roddy R, Lai JJ, Linton K, Mauck C.
    Contraception; 2007 Sep; 76(3):245-9. PubMed ID: 17707724
    [Abstract] [Full Text] [Related]

  • 33. Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro.
    Lai BE, Geonnotti AR, Desoto MG, Montefiori DC, Katz DF.
    Antiviral Res; 2010 Nov; 88(2):143-51. PubMed ID: 20709109
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pushing the frontiers of science--the Population Council's Microbicide Basic Science Network on vaginal microbicide research.
    Johansson ED, Maguire RA, Phillips DM.
    Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S117-24. PubMed ID: 10661749
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. "Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gels.
    van den Berg JJ, Rosen RK, Bregman DE, Thompson LA, Jensen KM, Kiser PF, Katz DF, Buckheit K, Buckheit RW, Morrow KM.
    AIDS Behav; 2014 May; 18(5):862-70. PubMed ID: 24248674
    [Abstract] [Full Text] [Related]

  • 38. Specific microbicides in the prevention of HIV infection.
    Kelly CG, Shattock RJ.
    J Intern Med; 2011 Dec; 270(6):509-19. PubMed ID: 21917029
    [Abstract] [Full Text] [Related]

  • 39. Design aspects of vaginal applicators that influence acceptance among target users.
    Bakke AJ, Zaveri T, Higgins MJ, Ziegler GR, Hayes JE.
    Sci Rep; 2021 May 07; 11(1):9802. PubMed ID: 33963262
    [Abstract] [Full Text] [Related]

  • 40. High-risk women's willingness to try a simulated vaginal microbicide: results from a pilot study.
    Mosack KE, Weeks MR, Novick Sylla L, Abbott M.
    Women Health; 2005 May 07; 42(2):71-88. PubMed ID: 16537301
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.